East Renfrewshire has one of the lowest levels of avoidable deaths in Scotland, a new report has revealed.

Data published by National Records of Scotland (NRS) shows that 598 fatalities in the local area between 2019 and 2021 could have been prevented or treated.

Researchers looked at all deaths of people under the age of 75 that were registered in the 32 council areas across Scotland.

Avoidable deaths are those which are considered either preventable or treatable through public health or healthcare interventions.

East Renfrewshire’s avoidable death rate was 226 per 100,000 residents.

Only East Dunbartonshire and the Orkney Islands had lower levels.

Glasgow had the highest rate, at 497.

Of the 598 avoidable deaths in East Renfrewshire over the two-year period, 383 were classed as ‘preventable’ and 215 were ‘treatable.’ The report also shows that 28% of the 63,587 deaths registered in Scotland last year were considered preventable or treatable.

Across the country, the rate of avoidable deaths in 2021 was 4% higher than the previous year, with half of this increase attributable to deaths linked to Covid-19.

However, cancers and circulatory diseases were the most common causes of avoidable mortality, accounting for 28% and 25% respectively.

Alcohol and drug-related avoidable mortality rates increased for the ninth year in a row, with 53 deaths per 100,000 people in 2021.

The NRS report also found that the highest rates of avoidable mortality were found in the poorest areas of Scotland, with the lowest in the more affluent parts.

Julie Ramsay, head of vital events statistics at NRS, said: “Avoidable mortality doesn’t impact everyone equally.

“The rate of avoidable deaths in the most deprived areas was over four times the rate of those in the least deprived areas.”

The Scottish Government stressed that, over the long term, avoidable mortality has fallen, adding that it is “taking action to reduce inequalities in health.”

A spokesman said: “We are working hard to address alcohol and drug-related deaths, making it easier for people to access treatment regardless of their circumstances, and cancer treatment remains a key priority, with the 31-day waiting time standard consistently met throughout the Covid-19 pandemic.”